StockData
Intelligent Bio Solutions Inc. logo

Intelligent Bio Solutions Inc. (INBS) income statement

INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3057% below fair value
$1.54−0.02 (-1.28%)

Close on Nov 18, 2026Market cap $4.66MP/E –Yield –

Intelligent Bio Solutions Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
48.6%
Operating margin
-299.1%
Net margin
-294.9%
Return on equity, FY2026
-292.3%

Financial strength

Current ratio
1.44
Debt to equity
–
Debt to assets
–
Cash to current liabilities
81.0%

Valuation

P/E ratio
–
Price to sales
1.11
Price to book
0.85
Dividend yield
–

See a number that looks wrong?